Related Experiment Video
Updated: Jun 12, 2026

06:55
Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing
Published on: May 8, 2021
5.7K
Non-invasive detection of COVID-19 using a microfluidic-based colorimetric sensor array sensitive to urinary
Mohammad Mahdi Bordbar1, Hosein Samadinia1, Azarmidokht Sheini2
1Chemical Injuries Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mikrochimica Acta
|August 4, 2022
Summary
A novel paper-based sensor array detects COVID-19 by analyzing urine metabolites. This rapid, low-cost method shows potential for identifying various diseases through unique colorimetric fingerprints.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Point-of-Care Diagnostics
Background:
- Current COVID-19 detection methods can be costly and time-consuming.
- There is a need for rapid, accessible diagnostic tools for infectious diseases and metabolic disorders.
Purpose of the Study:
- To develop and evaluate a colorimetric sensor array for detecting COVID-19 using urine metabolites.
- To assess the sensor's potential for identifying other diseases like chronic kidney disease, liver disorder, and diabetes.
Main Methods:
- A microfluidic paper-based sensor array utilizing gold/silver nanoparticles, metalloporphyrins, metal ion complexes, and pH indicators was designed.
- Urine samples from COVID-19 patients, healthy controls, and cured individuals were analyzed.
- Color changes were visually observed and quantified using image analysis software and principal component analysis-discriminant analysis.
Main Results:
- The sensor array generated distinct color patterns ('fingerprints') for different participant groups.
- The assay achieved sensitivities of 73.3% for COVID-19 patients, 74.5% for healthy controls, and 66.6% for cured individuals.
- The sensor demonstrated potential for detecting other metabolic disorders beyond COVID-19.
Conclusions:
- The developed sensor array offers a feasible, rapid, and cost-effective alternative for disease detection.
- Further studies with larger sample sizes are needed to validate the sensor's performance for various diseases.
- This technology holds promise for point-of-care diagnostics of infectious and metabolic diseases.

